Pain Processing in Inflammatory and Non-Inflammatory Chronic Pain Syndromes

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-70
SponsorUniversity of Florida

About this trial

Fibromyalgia (FM) is a chronic musculoskeletal pain disorder that afflicts up to 4% of the general population. The evaluation of pain mechanisms in FM has shown predominant central abnormalities and therefore has been designated as nociplastic pain syndrome. Rheumatoid arthritis (RA) is characterized by polyarthritis and pain from inflamed tissues, consistent with nociceptive pain. FM and RA patients may utilize overlapping pain mechanisms resulting in nociceptive and nociplastic pain.

Eligibility criteria

Qualifiers

Ages 18-70

Fulfills the 1990 and 2011 American College of Rheumatology Criteria for FM

Fulfills the 2010 ACR-EULAR classification criteria for RA

Healthy volunteers: No significant pain/fatigue/depression/anxiety.

Disqualifiers

Diabetes

Cancer

Advanced liver, kidney or cardiovascular disease

Neuropathic pain

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

150 Participants
are grouped into 3 trial groups

Sponsors and collaborators